ArticleOncotarget2017

The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.

Bum Jun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.